Company / Operating Income
BioAge Labs, Inc. Operating Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$92.8M
FY2025
5-year range
-$92.8M / -$48.4M
FY2023-FY2025
Trend
-18.7%
vs FY2024
Sector context
#89 of 204
Health Care
What the data says
At -$93M, BioAge Labs, Inc.'s operating income ranks #89 of 204 in the Health Care sector. Declined from -$48M to -$93M over the past 2 years.
Based on SEC 10-K filings.
-$93M in FY2025.
Declined from -$48M to -$93M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 204 in Health CareTop 44% of 204This company -$92.8M Sector average $107.7M
▼
-186.1% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 18.7% year-over-year.
- Ranks #89 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$92.8M | -18.7% |
| FY2024 | -$78.2M | -61.6% |
| FY2023 | -$48.4M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026